Upon being FDA approved in December 2025, the Wegovy pill became the first version of oral semaglutide (as well as the first oral GLP-1) specifically approved for weight loss
Because the metabolic foundation was never rebuilt, appetite returns, dysbiosis persists, SCFAs remain low, and circadian signals remain disrupted
Importantly, the platform effect for gastrointestinal and hepatobiliary side-effects proved robust: regardless of whether the full or core sample was used, TikTok consistently displayed a higher prevalence of these intuitively perceptible adverse events than Bilibili or RedNote, indicating that the platforms algorithm or audience preference amplifies the visibility of such salient toxicities
History Edvard Engesaeth and Hans Gangesterkar co-founded Nurx
These adjustments can significantly improve your chances of overcoming insomnia on GLP-1 and achieving better rest: Keep a consistent routine: Our bodies thrive on routine
Its also lacking in nutritional value
